Gikakis Nicolas 4

What Happened

• Nicolas Gikakis, a director of Aethlon Medical (AEMD), had 2,182 shares of common stock forfeited on June 30, 2026 to cover tax withholding obligations. The shares were valued at $0.82 each, totaling about $1,789. This was a tax-withholding disposition related to the conversion of vested restricted stock units (RSUs), not an open-market sale.

Key Details

• Transaction date and price: 2026-06-30; 2,182 shares at $0.82 per share.
• Transaction code: F (tax withholding/forfeiture).
• Related conversion: The forfeited shares were used to cover taxes upon conversion of an aggregate 5,454 vested RSUs into common stock.
• Origin of grant: Those RSUs were part of a grant disclosed in the Reporting Person’s Form 4 filed April 17, 2026.
• Shares owned after transaction: Not specified in the filed Form 4.
• Filing: Form 4 filed 2026-07-01 (appears timely).

Context

• This was a routine tax-withholding action (sometimes called a "cashless" or share-withholding to cover taxes) tied to vested RSUs, not an independent sale or purchase that necessarily signals insider sentiment. For retail investors, such withholdings are common and typically reflect standard payroll/tax procedures rather than trading decisions.